Published Report - Point-of-Care Molecular Diagnostics Market Outlook and Strategic Insights by 2028
- Status : Published
- Report Code : TIPAR00003144
- Category : Life Sciences
- No. of Pages : 208
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
In 2021, the assays and kits segment is estimated to account for the largest market share in the global point-of-care molecular diagnostics market. POC molecular diagnostic assays and kits are specially designed for point of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts. POC molecular diagnostics assays and kits enable the early diagnosis of infectious diseases, cancer, and women’s health and sexual health conditions among others.
Asia Pacific is expected to be the fastest growing region in the point-of-care molecular diagnostics market. The growth of the point-of-care molecular diagnostics market in this region is primarily due to rising incidences of chronic diseases associated with geriatric population, expansion of key market players in this region, insufficient sophisticated central laboratory testing services, and potential cost effectiveness of POC molecular diagnosis.
Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing, due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes.
Increasing demand for diagnostic tools to control and eliminate infectious diseases, timely detection of causative agent, allowing effective treatment and disease control will fuel the market during the forecast period.
Various companies have made organic growth strategies in the point-of-care molecular diagnostics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as F. Hoffmann-La Roche Ltd, Danaher amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
North America dominates the global point-of-care molecular diagnostics market. Ongoing efforts by major market participants to strengthen their market position is an important factor contributing to the major share. Furthermore, several clinical studies investigating the efficiency and accuracy of novel molecular tests are also expected to contribute towards the market growth over the forecast period. Growing demand for rapid diagnosis and development of newer molecular diagnostic tests for DNA analysis have poised the region as a major market space.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Point-of-Care Molecular Diagnostics Market – By Product and Services
1.3.2 Global Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 Global Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 Global Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 Global Point-of-Care Molecular Diagnostics Market– By Geography
2. Global Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– Global Analysis
6.1 Global Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
6.2 Global Point-of-Care Molecular Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product and Services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product and Services 2021 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. Global Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 North America: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.2 Europe: Point-of-Care Molecular Diagnostics Market
11.2.1 Overview
11.2.2 Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.2.4 Europe: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.2.5 Europe: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.2.6 Europe: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.2.7 Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.2.7.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.2 UK: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.1.3 UK: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.1.4 UK: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.1.5 UK: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.2 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.2 Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.2.3 Germany: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.2.4 Germany: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.2.5 Germany: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.3 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.2 France: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.3.3 France: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.3.4 France: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.3.5 France: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.4 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.2 Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.4.3 Italy: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.4.4 Italy: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.4.5 Italy: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.5 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.2 Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.5.3 Spain: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.5.4 Spain: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.5.5 Spain: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.2.7.6 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.2 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market
11.3.1 Overview
11.3.2 Asia Pacific: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.4 Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.5 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.6 Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.3 China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.4 China: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.1.5 China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.2 Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.3 Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.4 Japan: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.2.5 Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.3 India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.3 India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.4 India: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.3.5 India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.4 Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.3 Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.4 Australia: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.4.5 Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.5 South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.3 South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.4 South Korea: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.5.5 South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3.7.6 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.3 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.4 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.3.7.6.5 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.4 Middle East & Africa: Point-of-Care Molecular Diagnostics Market
11.4.1 Overview
11.4.2 Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.4.4 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.4.5 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.4.6 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.4.7 Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.4.7.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.1.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.1.2 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.1.3 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.1.4 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.1.5 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.2 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.2.1 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.2.2 South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.2.3 South Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.2.4 South Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.2.5 South Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.3 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.1 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.3.2 UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.3.3 UAE: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.3.4 UAE: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.3.5 UAE: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.4.7.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.4.1 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.7.4.2 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.4.7.4.3 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.4.7.4.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.4.7.4.5 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5 South and Central America: Point-of-Care Molecular Diagnostics Market
11.5.1 Overview
11.5.2 South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.3 South and Central America: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.5.4 South and Central America: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.5.5 South and Central America: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.5.6 South and Central America: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.5.7 South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.5.7.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.1.2 Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.1.3 Brazil: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.1.4 Brazil: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.1.5 Brazil: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5.7.2 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.1 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.2.2 Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.2.3 Argentina: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.2.4 Argentina: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.2.5 Argentina: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.5.7.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.1 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.5.7.3.2 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.5.7.3.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.5.7.3.4 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.5.7.3.5 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 Overview – Impact of COVID-19
12.2 Impact of COVID-19 on Point-of-Care Molecular Diagnostic Market
12.3 North America: Impact Assessment of COVID-19 Pandemic
12.4 Europe: Impact Assessment of COVID-19 Pandemic
12.5 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.6 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.7 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 binx health, inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. US Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product and Services -Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product and Services -Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 29. France: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 47. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 48. Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 49. China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 50. China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 51. China: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 52. China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 54. Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 55. Japan: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 56. Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 57. India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 58. India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 59. India: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 60. India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 61. Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 62. Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 63. Australia: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 64. Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 68. South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 74. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 77. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 78. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 79. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 80. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 81. South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 82. South Africa: Point-of-Care Molecular Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
Table 83. South Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 84. South Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 85. UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 86. UAE: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 87. UAE: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 88. UAE: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 93. South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 95. South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 97. Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 98. Brazil: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 101. Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 102. Argentina: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 109. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 110. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 111. Glossary of Terms, Point-of-Care Molecular Diagnostics Market
LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. Point-of-Care Molecular Diagnostics Market Segmentation, By Region
Figure 3. Global Point-of-Care Molecular Diagnostics Market Overview
Figure 4. Assays and Kits Segment Held the Largest Share by Product and Services in Point-of-Care Molecular Diagnostics Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Point-of-Care Molecular Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Point-of-Care Molecular Diagnostics Market– Leading Country Markets (US$ Million)
Figure 8. Global Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Global Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 15. Global Point-of-Care Molecular Diagnostics Market – By Geography Forecast and Analysis – 2021- 2028
Figure 16. Market Positioning of Key Players in Global Point-of-Care Molecular Diagnostics Market
Figure 17. Point-of-Care Molecular Diagnostics Market, by Product and Services 2021 & 2028 (%)
Figure 18. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)
Figure 22. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)
Figure 26. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)
Figure 33. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 38. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 39. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 40. US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Europe: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 44. Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 46. UK: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Germany: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. France: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Italy: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Spain: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of Europe: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 53. Asia Pacific: Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 54. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 55. China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 62. Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 64. Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 65. South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. South and Central America: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 69. South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 71. Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 72. Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 74. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America
Figure 75. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Europe
Figure 76. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Asia-Pacific
Figure 77. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Middle East and Africa
Figure 78. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in South and Central America
Figure 79. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For